Sleeve Gastrectomy Is a Safe and Efficient Procedure in HIV Patients with Morbid Obesity

a Case Series with Results in Weight Loss, Comorbidity Evolution, CD4 Count, and Viral Load

Marinos Fysekidis, Régis Cohen* (Corresponding Author), Mohamed Bekheit, Joseph Chebib, Abdelghani Boussairi, Hélène Bihan, Marie Aude Khuong, Laurent Finkielsztejn, Gabriela Mendoza, Sophie Abgrall, Djiba Condé, Jean Marc Catheline

*Corresponding author for this work

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: The efficacy and safety of bariatric surgery have been poorly studied in patients affected with HIV. Although sleeve gastrectomy (SG) is the most widely used procedure in many countries, most of the published literature reported results with the gastric bypass (GBP) procedure on morbidly obese HIV patients.Methods: We have evaluated retrospectively, in eight consecutive patients who underwent a SG, its effect in weight loss and its impact on the treatment and on the markers of HIV infection.Results: Seven out of eight patients were females. The mean age was 46 years, with a median preoperative BMI of 42 kg/m 2 . The mean duration of HIV infection and CD4 cell count were 13.4 years and 457 cells/mm 3 , respectively. The mean weight loss was 37 kg in 20 months, the excess BMI loss was 80.8 ± 30.9 %, and the excess weight loss is 81.5 ± 28.9 % with one minor complication. CD4 counts were unchanged. Three patients had therapy modifications that were unrelated to bariatric surgery. Two patients had a therapeutic drug monitoring before and after the intervention. Plasma concentrations remained in therapeutic levels after the SG. Most comorbidities disappeared postoperatively, decreasing the cardiovascular risk.Conclusions: The sleeve gastrectomy was safe and effective with no consequences on CD4 counts and viral load in HIV-affected obese patients. It should be considered as a part of the treatment in morbidly obese HIV patients.

Original languageEnglish
Pages (from-to)229-233
Number of pages5
JournalObesity Surgery
Volume25
Issue number2
Early online date27 Jun 2014
DOIs
Publication statusPublished - Feb 2015

Fingerprint

Morbid Obesity
Gastrectomy
CD4 Lymphocyte Count
Viral Load
Comorbidity
Weight Loss
HIV
Bariatric Surgery
HIV Infections
Gastric Bypass
Drug Monitoring
Therapeutics
Safety

Keywords

  • HIV
  • Obesity
  • Sleeve gastrectomy

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Sleeve Gastrectomy Is a Safe and Efficient Procedure in HIV Patients with Morbid Obesity : a Case Series with Results in Weight Loss, Comorbidity Evolution, CD4 Count, and Viral Load. / Fysekidis, Marinos; Cohen, Régis (Corresponding Author); Bekheit, Mohamed; Chebib, Joseph; Boussairi, Abdelghani; Bihan, Hélène; Khuong, Marie Aude; Finkielsztejn, Laurent; Mendoza, Gabriela; Abgrall, Sophie; Condé, Djiba; Catheline, Jean Marc.

In: Obesity Surgery, Vol. 25, No. 2, 02.2015, p. 229-233.

Research output: Contribution to journalArticle

Fysekidis, M, Cohen, R, Bekheit, M, Chebib, J, Boussairi, A, Bihan, H, Khuong, MA, Finkielsztejn, L, Mendoza, G, Abgrall, S, Condé, D & Catheline, JM 2015, 'Sleeve Gastrectomy Is a Safe and Efficient Procedure in HIV Patients with Morbid Obesity: a Case Series with Results in Weight Loss, Comorbidity Evolution, CD4 Count, and Viral Load', Obesity Surgery, vol. 25, no. 2, pp. 229-233. https://doi.org/10.1007/s11695-014-1350-7
Fysekidis, Marinos ; Cohen, Régis ; Bekheit, Mohamed ; Chebib, Joseph ; Boussairi, Abdelghani ; Bihan, Hélène ; Khuong, Marie Aude ; Finkielsztejn, Laurent ; Mendoza, Gabriela ; Abgrall, Sophie ; Condé, Djiba ; Catheline, Jean Marc. / Sleeve Gastrectomy Is a Safe and Efficient Procedure in HIV Patients with Morbid Obesity : a Case Series with Results in Weight Loss, Comorbidity Evolution, CD4 Count, and Viral Load. In: Obesity Surgery. 2015 ; Vol. 25, No. 2. pp. 229-233.
@article{6c7dda47c3eb4a2c8f2c3758df414983,
title = "Sleeve Gastrectomy Is a Safe and Efficient Procedure in HIV Patients with Morbid Obesity: a Case Series with Results in Weight Loss, Comorbidity Evolution, CD4 Count, and Viral Load",
abstract = "Background: The efficacy and safety of bariatric surgery have been poorly studied in patients affected with HIV. Although sleeve gastrectomy (SG) is the most widely used procedure in many countries, most of the published literature reported results with the gastric bypass (GBP) procedure on morbidly obese HIV patients.Methods: We have evaluated retrospectively, in eight consecutive patients who underwent a SG, its effect in weight loss and its impact on the treatment and on the markers of HIV infection.Results: Seven out of eight patients were females. The mean age was 46 years, with a median preoperative BMI of 42 kg/m 2 . The mean duration of HIV infection and CD4 cell count were 13.4 years and 457 cells/mm 3 , respectively. The mean weight loss was 37 kg in 20 months, the excess BMI loss was 80.8 ± 30.9 {\%}, and the excess weight loss is 81.5 ± 28.9 {\%} with one minor complication. CD4 counts were unchanged. Three patients had therapy modifications that were unrelated to bariatric surgery. Two patients had a therapeutic drug monitoring before and after the intervention. Plasma concentrations remained in therapeutic levels after the SG. Most comorbidities disappeared postoperatively, decreasing the cardiovascular risk.Conclusions: The sleeve gastrectomy was safe and effective with no consequences on CD4 counts and viral load in HIV-affected obese patients. It should be considered as a part of the treatment in morbidly obese HIV patients.",
keywords = "HIV, Obesity, Sleeve gastrectomy",
author = "Marinos Fysekidis and R{\'e}gis Cohen and Mohamed Bekheit and Joseph Chebib and Abdelghani Boussairi and H{\'e}l{\`e}ne Bihan and Khuong, {Marie Aude} and Laurent Finkielsztejn and Gabriela Mendoza and Sophie Abgrall and Djiba Cond{\'e} and Catheline, {Jean Marc}",
year = "2015",
month = "2",
doi = "10.1007/s11695-014-1350-7",
language = "English",
volume = "25",
pages = "229--233",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Sleeve Gastrectomy Is a Safe and Efficient Procedure in HIV Patients with Morbid Obesity

T2 - a Case Series with Results in Weight Loss, Comorbidity Evolution, CD4 Count, and Viral Load

AU - Fysekidis, Marinos

AU - Cohen, Régis

AU - Bekheit, Mohamed

AU - Chebib, Joseph

AU - Boussairi, Abdelghani

AU - Bihan, Hélène

AU - Khuong, Marie Aude

AU - Finkielsztejn, Laurent

AU - Mendoza, Gabriela

AU - Abgrall, Sophie

AU - Condé, Djiba

AU - Catheline, Jean Marc

PY - 2015/2

Y1 - 2015/2

N2 - Background: The efficacy and safety of bariatric surgery have been poorly studied in patients affected with HIV. Although sleeve gastrectomy (SG) is the most widely used procedure in many countries, most of the published literature reported results with the gastric bypass (GBP) procedure on morbidly obese HIV patients.Methods: We have evaluated retrospectively, in eight consecutive patients who underwent a SG, its effect in weight loss and its impact on the treatment and on the markers of HIV infection.Results: Seven out of eight patients were females. The mean age was 46 years, with a median preoperative BMI of 42 kg/m 2 . The mean duration of HIV infection and CD4 cell count were 13.4 years and 457 cells/mm 3 , respectively. The mean weight loss was 37 kg in 20 months, the excess BMI loss was 80.8 ± 30.9 %, and the excess weight loss is 81.5 ± 28.9 % with one minor complication. CD4 counts were unchanged. Three patients had therapy modifications that were unrelated to bariatric surgery. Two patients had a therapeutic drug monitoring before and after the intervention. Plasma concentrations remained in therapeutic levels after the SG. Most comorbidities disappeared postoperatively, decreasing the cardiovascular risk.Conclusions: The sleeve gastrectomy was safe and effective with no consequences on CD4 counts and viral load in HIV-affected obese patients. It should be considered as a part of the treatment in morbidly obese HIV patients.

AB - Background: The efficacy and safety of bariatric surgery have been poorly studied in patients affected with HIV. Although sleeve gastrectomy (SG) is the most widely used procedure in many countries, most of the published literature reported results with the gastric bypass (GBP) procedure on morbidly obese HIV patients.Methods: We have evaluated retrospectively, in eight consecutive patients who underwent a SG, its effect in weight loss and its impact on the treatment and on the markers of HIV infection.Results: Seven out of eight patients were females. The mean age was 46 years, with a median preoperative BMI of 42 kg/m 2 . The mean duration of HIV infection and CD4 cell count were 13.4 years and 457 cells/mm 3 , respectively. The mean weight loss was 37 kg in 20 months, the excess BMI loss was 80.8 ± 30.9 %, and the excess weight loss is 81.5 ± 28.9 % with one minor complication. CD4 counts were unchanged. Three patients had therapy modifications that were unrelated to bariatric surgery. Two patients had a therapeutic drug monitoring before and after the intervention. Plasma concentrations remained in therapeutic levels after the SG. Most comorbidities disappeared postoperatively, decreasing the cardiovascular risk.Conclusions: The sleeve gastrectomy was safe and effective with no consequences on CD4 counts and viral load in HIV-affected obese patients. It should be considered as a part of the treatment in morbidly obese HIV patients.

KW - HIV

KW - Obesity

KW - Sleeve gastrectomy

UR - http://www.scopus.com/inward/record.url?scp=84939894058&partnerID=8YFLogxK

U2 - 10.1007/s11695-014-1350-7

DO - 10.1007/s11695-014-1350-7

M3 - Article

VL - 25

SP - 229

EP - 233

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 2

ER -